Vytorin Side Effects

Name: Vytorin

Generic: Ezetimibe and Simvastatin

Manufacturer: Merck/Schering-Plough

Date approved: July 23, 2004

Status: Prescription only

Approved uses: Approved for the treatment of dyslipidemia, a disruption in the amount of lipids in the blood.

Off-Label uses: Has a possible off-label ability to eliminate blood vessel inflammation often associated with being the cause of high BP

Side effects:
  • Rhabdomyolysis - serious muscle damage linked to Simvastatin, an ingredient in Vytorin
  • Myopathy - Muscle Toxicity
  • Liver Damage
Related topics: Zetia, Zocor, Unsafe Drugs, Simvastatin, Cholesterol

Common Misspellings: Vitorin, Vitoran, vitoryn, vitoran, vyotrin


Vytorin (Ezetimibe/simvastatin)

Vytorin, which is a combination of two drugs: ezetimibe (marketed as Zetia in the United States) and the statin drug simvastatin (marketed as Zocor). Vytorin is prescribed for the treatment of dyslipidemia, which occurs when the amount of lipids in the bloodstream is disrupted. In the U.S., this usually involves an elevation of lipids due to diet or lifestyle. The Zocor in Vytorin is designed to combat the disease by blocking an enzyme in the blood that enables the body's production of cholesterol, while the Zetia is meant to reduce the amount of cholesterol that the body absorbs from food.

However, an extensive study completed in mid 2006, and released in January 2008 has shown that taking Vytorin had no benefit on the buildup of artery plaque when compared with patients taking only Zocor. This finding is significant, as Vytorin is three times more expensive than the generic version of Zocor (simvastatin). The manufacturer has disputed the study's findings, but within weeks of the study's release a class action lawsuit has already been filed against Merck and Schering-Plough. The Vytorin lawsuit alleges that the companies have known since 2006 that their drug was no more effective than the cheaper generic Zocor, despite leading consumers to believe the opposite.


Merck Agrees to Pay $41.5 Million in Vytorin Class Action Lawsuit

Merck Agrees to pay $41.5 million in Vytorin Class Action Lawsuit. The makers of the popular cholesterol drugs, Vytorin and Zetia, have agreed to pay $41.5 million in a Vytorin class action lawsuit. Merck and Schering-Plough were accused of withholding unfavorable study results about the pharmaceutical blockbusters, Vytorin and Zetia, which showed that the drugs were not as effective at unclogging arteries as other less expensive alternatives. read more

Three Studies Report Possible Vytorin-cancer Link

Three studies Report Possible Vytorin -cancer link. Three separate studies of the cholesterol-lowering combination drug Vytorin have reported results that show a possible connection between the drug and the development of cancer. Pedersen found that while the drug did not change the outcome of patients experiencing heart attacks, strokes, or surgeries related to the aortic valve in question, the number of cancer development cases in those taking Vytorin were greater than those patients taking the placebo. read more

View the Vytorin Law Articles page here


Vytorin News Articles

Do most people fear side effects of prescriptions & would they prefer foods or supplements?

logowanie - esculap

View the Vytorin News Articles page here


Vytorin Newsfeeds

Merck, Schering Launch Huge Heart-Drug Test

Students Rally Together Against Legislation at State Capitol

View the Vytorin Newsfeeds page here


Vytorin Wikipedia

Ezetimibe/simvastatin

Ezetimibe

View the Vytorin Wikipedia page here

Need A Vytorin Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Vytorin Case - Submit Your Information Below

Do you need legal assistance with your Vytorin case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Vytorin Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.